FIELD: organic chemistry. SUBSTANCE: method involves synthesis of pure isoflavone derivatives of the formula (I) given in description where R - hydrogen or isopropyl; R2 and R3 - hydrogen or C1-C2-alkoxy-group. Synthesis is carried out by cyclization of resorcinol derivative of the formula (II) given in description with ethyl-ortho-formate at 70-100 C (preferably at 80-90 C) in the presence of organic solvent (preferably in dimethylformamide and/or isopropanol) at 0.3-2-fold quantity with respect to measured volume of resorcinol derivatives of the formula (III) given in description, and/or in the presence of ethyl-ortho-formate excess for preparing 20-70% supersaturated solution of product of the formula (III). The latter is isolated continuously from the mixture following by cooling of reaction mixture and separation of compound of the formula (II) by filtration where R1 - hydrogen; R2 and R3 - see above, and/or by addition of nonpolar or polar solvent to reaction mixture with selective dissolving of formed by-side product of the formula (V) given in description where R1 - hydrogen; R2 and R3 - see above, and/or addition of almost equivalent quantity of anhydrous potassium carbonate to reaction mixture and isolation of crystallized out double salt of the formula (IV) given in description where R2 and R3 - see above. Then compound of the formula (IV) or (I) where R1 - hydrogen is alkylated with haloidalkyl, and the end pure product of the formula (I) is isolated where R1 - isopropyl and containing not more 0.5% polluting impurity of compound of the formula (V). Double salt is formed after addition of nonpolar solvent (preferable toluene) and anhydrous potassium carbonate at 40-80 C (preferably at 60 C). Ethanol formed in cyclization reaction is remained in reaction medium. Purity of the end product is above 99.8% . Synthesized compounds were used in medicine. EFFECT: improved method of synthesis. 4 cl
Title | Year | Author | Number |
---|---|---|---|
PROCESS FOR PREPARING KETONES OR SALTS THEREOF | 1990 |
|
RU2065848C1 |
METHOD OF SYNTHESIS OF QUINOLINECARBOXYLIC ACID DERIVATIVES | 1988 |
|
RU2014331C1 |
METHOD OF SYNTHESIS OF QUINOLINE CARBOXYLIC ACID DERIVATIVES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS | 1988 |
|
RU2049783C1 |
METHOD OF SYNTHESIS OF PROPARGYL AMMONIUM CHLORIDE DERIVATIVES | 1994 |
|
RU2130450C1 |
METHOD OF SYNTHESIS OF QUINOLINE CARBOXYLIC ACID OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS AND COMPOUNDS | 1990 |
|
RU2044734C1 |
METHOD OF SYNTHESIS OF DERIVATIVES OF O-(2-HYDROXY-3-PIPERIDINO-1-PROPYL)-NICOTINIC ACID AMIDEOXIME AND THEIR SALTS (VARIANTS), O-(2-HYDROXY-3-PIPERIDINO-1-PROPYL)-NICOTINIC ACID AMIDEOXIME PURE CRYSTALLINE BASE | 1990 |
|
RU2074854C1 |
ANTIMICROBIAL COMPOSITION | 1991 |
|
RU2030913C1 |
PROCESS FOR PREPARING PHENYLKYLAMINES OR SALTS OF THESE COMPOUNDS | 1990 |
|
RU2015960C1 |
TLATRATE OF 7-ISOPROPOXYISOFLAVONE AND CYCLODEXTRINE POLYMER SHOWING ACTIVITY AGAINST OSTEOPOROSIS AND OSTEOMALACIA | 1987 |
|
RU2022970C1 |
METHOD OF SYNTHESIS OF PHENYLALKYLAMINES OF THEIRS PHARMACOLOGICALLY ACCEPTABLE SALTS | 1989 |
|
RU2007384C1 |
Authors
Dates
1995-06-09—Published
1991-12-05—Filed